Taemin Kim is an experienced patent attorney in the fields of chemicals, pharmaceuticals, semiconductor materials, and agricultural science. He has a successful track record of representing multinational corporations based in the United States, Europe, and Japan in patent prosecution cases before the Korean Intellectual Property Office (KIPO), as well as patent trials and litigations – including invalidation actions, scope confirmation actions, and infringement actions – before the Intellectual Property Trial and Appeal Board (IPTAB), the Korean Patent Court, and the Supreme Court. He has also handled Freedom-to-Operate (FTO) and validity analyses.

His practice primarily focuses on patent prosecution and litigation related to pharmaceuticals. Especially with respect to patent term extensions (PTEs) of pharmaceutical patents, he presented opinions on how to revise the relevant laws, made presentations at public hearings held by the KIPO, and prepared and submitted an expert opinion in a litigation in a foreign jurisdiction. Drawing from this wealth of knowledge and experience, he has obtained favorable decisions for pharmaceutical companies as patentees in major PTE litigations in Korea.